| mRNA |
17-AAG |
FIMM |
pan-cancer |
AAC |
0.029 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.026 |
0.9 |